China Mengniu Dairy Company (2319) H2 2025 earnings summary

Executive summary

• Full-year revenue was RMB 82.24 billion, down 7.3% year-over-year, with gross profit margin rising 0.3 points to 39.9% and operating profit at RMB 6.56 billion (8.0% margin).

• Adjusted profit attributable to owners was RMB 3.96 billion, while net profit attributable to owners surged 1,378.9% to RMB 1.55 billion due to lower impairments.

• EBITDA margin rose 2.7ppt to 7.7% year-over-year, with EBITDA at RMB 6,362.1 million.

• Product innovation and diversification, especially in fresh milk, infant and adult milk formula, and cheese, drove double-digit growth in these segments.

• Strategic focus on channel optimization, international expansion, and digital transformation.

Financial highlights

• Gross profit was RMB 32,808 million, down from RMB 35,090.4 million in 2024.

• Selling expenses decreased by 6.5% to RMB 21.59 billion, but expense ratios rose slightly due to negative operating leverage.

• Operating cash flow reached a record RMB 8.75 billion, with free cash flow at RMB 6.3 billion.

• CapEx was tightly controlled, falling to RMB 2.45 billion.

• Debt-to-equity ratio improved to 53.8% from 72.1% in 2024.

Outlook and guidance

• Three-year shareholder return plan (2025–2027) targets steady dividend increases and continued share buybacks.

• Industry recovery is underway, with policy support, market stabilization, and focus on functional and solid dairy products expected to drive growth.

• Emphasis on R&D innovation, digital transformation, and channel upgrades to lead high-quality development.

• Plans to launch high-protein milk leveraging proprietary technology to meet evolving consumer needs.

• 2026 positioned as a critical year for strategic execution and supply-demand balance.